Summary
Updated Aug 31, 2026
Jonathan Robert Hunt is Chief Accounting Officer of Perspective Therapeutics, Inc. (CATX). 3 SEC Form 4 filings on record going back to 2024, most recently on 4 March 2026. Most recent open-market trade: bought $22K of CATX on 17 November 2025. Lifetime open-market purchases: $71K. Historical track record: 1/5 stars across 5 tracked purchases.
Recent Transactions
5Every recent SEC Form 4 transaction Jonathan Robert Hunt has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 20% |
| 90-day win rate | 20% |
| Avg 5-day return | +12.00% |
| Avg 30-day return | -4.13% |
| Avg 90-day return | +6.34% |
| Best 30-day return | +22.71% |
Trading Pattern
InsiderAlpha's records for Jonathan Robert Hunt go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $14K (5 buys totaling $71K). The largest single buy on record is $39K of CATX in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan Robert Hunt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert F. Williamson III - $20K of CATX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jonathan Robert Hunt?
Jonathan Robert Hunt is a corporate insider, tracked as Chief Accounting Officer of Perspective Therapeutics, Inc. (CATX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jonathan Robert Hunt last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 3 filings going back to 2024.
Has Jonathan Robert Hunt been buying or selling stock?
Recorded transactions: 5 open-market purchases ($71K) and 0 open-market sales across all tracked filings.
How accurate is Jonathan Robert Hunt's historical track record?
Across 5 tracked purchases, Jonathan Robert Hunt averaged -4.1% avg 30-day return with a 20% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Jonathan Robert Hunt's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jonathan Robert Hunt and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial